Albemarle Corp (ALB) Stock Analysis and Metrics

Albemarle

NYSE: ALB

$114.80 ▼ -2.11 (-1.80%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap13.55 Bn

P/E-28.80

P/S2.47

Div. Yield0.02

Total Debt (Qtr)1.96 Bn

Revenue Growth (1y) (Qtr)32.67

Add ratio to table…

About

Albemarle Corporation is a world leader in transforming essential resources into critical ingredients for mobility energy connectivity and health. The company’s purpose is to enable a more resilient world by partnering to pioneer new ways to move power connect and protect. Albemarle serves end markets that include grid storage automotive aerospace conventional energy electronics construction agriculture and food pharmaceuticals and medical devices. It operates more than twenty five production and research and development facilities worldwide and maintains administrative and sales offices in many regions. As of December 31 2025 Albemarle served approximately nineteen hundred customers in about seventy countries.

Albemarle generates revenue primarily through the sale of lithium compounds bromine specialty chemicals and catalyst products. In its Energy Storage segment it sells lithium carbonate lithium hydroxide and lithium chloride for use in batteries power grids solar panels greases and specialty glass. The Specialties segment offers brominated fire safety compounds lithium specialties for pharmaceuticals bromine specialties for food and water safety and value added lithium products such as butyllithium and lithium aluminum hydride. The Ketjen segment provides hydroprocessing catalysts fluidized catalytic cracking catalysts additives and performance catalyst solutions including organometallics and curatives. The company also earns revenue from technical services recycling services and licensing of its intellectual property.

The company operates through the following three reportable segments: Energy Storage Specialties and Ketjen.

• Energy Storage develops and manufactures basic lithium compounds including lithium carbonate lithium hydroxide and lithium chloride. These materials are used in lithium batteries for consumer electronics and electric vehicles in power grid storage and solar panels in high performance greases and in specialty glass for appliances and electronics. The segment sources lithium from its 49 percent owned joint venture Windfield Holdings Pty Ltd which controls the Talison Lithium mine in Australia from its 50 percent owned MARBL Lithium Joint Venture which holds the Wodgina hard rock lithium mine project in Western Australia and from solar evaporation ponds at the Salar de Atacama in Chile and at Silver Peak in Nevada. Additional lithium resources are held in Kings Mountain North Carolina and in Antofalla within the Catamarca Province of Argentina. Major competitors in the lithium market include Sociedad Quimica y Minera de Chile S A Sichuan Tianqi Lithium Jiangxi Ganfeng Lithium Rio Tinto plc Pilbara Minerals Tesla and numerous Chinese firms. Competition is based on index linked pricing product quality product diversity reliability of supply and customer service.

• Specialties optimizes a portfolio of bromine and highly specialized lithium solutions for energy mobility connectivity and health markets. The segment supplies brominated fire safety compounds that enable plastics to meet high heat performance requirements in electronics printed circuit boards wire and cable textiles and foam insulation. Lithium specialties act as precursors for many pharmaceuticals while bromine specialties help ensure safer food and water supplies. Other bromine based products include elemental bromine alkyl bromides inorganic bromides brominated powdered activated carbon and various bromine fine chemicals. Value added lithium specialties comprise butyllithium lithium aluminum hydride and the segment also produces cesium products and zirconium barium titanium materials for pyrotechnical applications such as airbag initiators. Technical services include handling of reactive lithium products and recycling of lithium byproducts from synthesis. Bromine is sourced from Arkansas brine rights and through a 50 percent interest in Jordan Bromine Company Limited which extracts bromine from the Dead Sea. Lithium concentrate for specialties comes from the same sources as the Energy Storage segment. Key competitors are Lanxess AG Israel Chemicals Ltd Rio Tinto and producers in India and China. Competition hinges on product performance quality price contract terms research and development process improvements specialized customer services ability to attract skilled personnel and safety record.

• Ketjen encompasses three product lines Clean Fuels Technologies fluidized catalytic cracking catalysts and performance catalyst solutions. Clean Fuels Technologies provides hydroprocessing catalysts together with isomerization and alkylation catalysts that remove sulfur nitrogen and other impurities from oil fractions improve product properties and support downstream processes. Fluidized catalytic cracking catalysts assist in high yield cracking of refinery petroleum streams into transportation fuels and petrochemical feedstocks such as propylene while additives reduce sulfur dioxide and nitrogen oxide emissions increase liquefied petroleum gas olefins yield and boost octane in gasoline. Performance catalyst solutions include organometallic co catalysts such as aluminum magnesium and zinc alkyls used to make alpha olefins polyolefins and electronic materials and curatives that cure polyurethanes epoxies and engineered resins. Raw materials for Ketjen operations consist of sodium silicate sodium aluminate kaolin aluminum ethylene alpha olefins isobutylene toluene and metals including lanthanum molybdenum nickel cobalt sourced from numerous independent suppliers under competitive contracts. Major competitors are Shell Catalysts & Technologies Advanced Refining Technologies Haldor Topsoe in the CFT market W R Grace & Co and BASF Corporation in the FCC market and Nouryon Lanxess AG and Arxada in the PCS market. Competition is driven by product performance quality price contract terms research and development process improvements specialized customer services technical support and safety record. Following the announced divestiture of Ketjen’s Refining Solutions business to ChemCat AcquisitionCo LLC and the sale of its 50 percent interest in Eurecat S A to Axens SA the company will retain the PCS business and a 49 percent interest in the resulting Holdco partnership.

Albemarle holds a leading position in the global lithium bromine and catalysts industries due to its world class resource base reliable supply chain leading process chemistry and high impact innovation. The company differentiates itself through customer centricity and a strong focus on people and planet which supports long term relationships with industrial clients. Its extensive footprint of more than twenty five production and R&D facilities across the Americas Asia Pacific Europe and the Middle East enables it to serve customers swiftly and consistently. Albemarle competes with firms such as Sociedad Quimica y Minera de Chile S A Lanxess AG Israel Chemicals Ltd Rio Tinto plc W R Grace & Co BASF Corporation Shell Catalysts & Technologies and various regional producers. These competitive advantages allow Albemarle to maintain market share and pursue growth in high demand sectors such as electric vehicle energy storage and clean fuels.

Albemarle serves a diverse customer base that includes automotive manufacturers electronics companies pharmaceutical firms refining companies agriscience businesses construction material producers and food and beverage processors. The company reports approximately nineteen hundred customers spread across about seventy countries worldwide. While the filing does not disclose specific customer names the breadth of served industries demonstrates the company’s broad market reach and reliance on long term contractual relationships.

Investment Thesis

▲ Bull case

Albemarle's Specialties segment is demonstrating resilient growth potential that the market is underestimating, particularly in bromine specialties, where operational improvements and favorable product mix are driving stronger-than-expected performance despite geopolitical headwinds. The company raised its full-year 2026 Specialties net sales guidance to $1.3 billion to $1.5 billion and adjusted EBITDA to $225 million to $275 million, reflecting confidence in pricing power and volume recovery, with EBITDA margin expected in the high teens. This outlook increase comes even as operations at the Jordan Bromine Company joint venture have fully recovered from late 2025 flooding and continue operating amid regional tensions, indicating underlying business strength. Furthermore, year-to-date cost and productivity improvements of $40 million put Albemarle on track to meet its full-year target of $100 million to $150 million, which is actively offsetting supply chain disruptions estimated at $70 million to $90 million in unmitigated cost impact. The Specialties segment's ability to deliver 30% year-over-year EBITDA growth in Q1, driven by higher pricing and favorable mix, suggests that management's conservative guidance may not fully capture the upside from bromine demand resilience in electronics, semiconductors, and building and construction end markets, especially as AI-driven electronics demand continues to strengthen in Asia and the Americas.
Albemarle's Energy Storage segment is positioned to benefit from structural shifts in lithium demand that are not fully reflected in current pricing assumptions, particularly the growing decoupling of EV unit sales from gigawatt hour (GWh) demand due to increasing battery sizes. Despite a 6% year-over-year drop in global EV unit sales in Q1, GWh-based EV sales rose 3% due to a 20% increase in average Chinese battery size, directly boosting lithium hydroxide demand. This trend is supported by shifting Chinese subsidies toward premium vehicle segments and robust EV growth in Europe (driven by policy support in Germany, France, and the U.K.) and developing markets (Brazil, India, Australia up 74% year-over-year). Albemarle remains on track to hit its 5-year CAGR target of 15% for energy storage volume growth, having already achieved 25% CAGR over the first three years, with moderate growth expected in 2026–2027 as large projects complete their ramp—requiring little to no additional CapEx. The company's scaled, low-cost resources at Wodgina, Greenbushes, and Salar de Atacama provide capital-efficient brownfield opportunities to fuel future growth, meaning that near-term volume stability does not impair long-term secular growth trajectories in energy storage and EVs.
Albemarle's balance sheet strength and proactive debt reduction are creating underappreciated financial flexibility that enables strategic optionality amid market volatility. Following the Q1 repayment of $1.3 billion in debt using proceeds from the Eurecat joint venture and Ketjen divestiture, the company reduced its weighted average interest rate to 3.1%, lowered annual interest expense by approximately $60 million, and ended the quarter with a net debt-to-EBITDA leverage ratio of 1x—with no major debt maturities until late 2028. This financial resilience allows Albemarle to navigate supply chain disruptions and geopolitical uncertainties without compromising its investment-grade profile, while maintaining the capacity to pursue value-accretive brownfield projects at existing assets like Greenbushes, Wodgina, and Salar de Atacama. The company's conservative balance sheet posture, combined with its ability to generate $346 million in operating cash flow and $248 million in free cash flow in Q1, positions it to capitalize on opportunistic investments during market downturns—such as advancing the Kings Mountain project or expanding DLE capabilities at Salar de Atacama—when others may be constrained by leverage concerns.

Albemarle's Specialties segment is demonstrating resilient growth potential that the market is underestimating, particularly in bromine specialties, where operational improvements and favorable product mix are driving stronger-than-expected performance despite geopolitical headwinds. The company raised its full-year 2026 Specialties net sales guidance to $1.3 billion to $1.5 billion and adjusted EBITDA to $225 million to $275 million, reflecting confidence in pricing power and volume recovery, with EBITDA margin expected in the high teens. This outlook increase comes even as operations at the Jordan Bromine Company joint venture have fully recovered from late 2025 flooding and continue operating amid regional tensions, indicating underlying business strength. Furthermore, year-to-date cost and productivity improvements of $40 million put Albemarle on track to meet its full-year target of $100 million to $150 million, which is actively offsetting supply chain disruptions estimated at $70 million to $90 million in unmitigated cost impact. The Specialties segment's ability to deliver 30% year-over-year EBITDA growth in Q1, driven by higher pricing and favorable mix, suggests that management's conservative guidance may not fully capture the upside from bromine demand resilience in electronics, semiconductors, and building and construction end markets, especially as AI-driven electronics demand continues to strengthen in Asia and the Americas.
Albemarle's Energy Storage segment is positioned to benefit from structural shifts in lithium demand that are not fully reflected in current pricing assumptions, particularly the growing decoupling of EV unit sales from gigawatt hour (GWh) demand due to increasing battery sizes. Despite a 6% year-over-year drop in global EV unit sales in Q1, GWh-based EV sales rose 3% due to a 20% increase in average Chinese battery size, directly boosting lithium hydroxide demand. This trend is supported by shifting Chinese subsidies toward premium vehicle segments and robust EV growth in Europe (driven by policy support in Germany, France, and the U.K.) and developing markets (Brazil, India, Australia up 74% year-over-year). Albemarle remains on track to hit its 5-year CAGR target of 15% for energy storage volume growth, having already achieved 25% CAGR over the first three years, with moderate growth expected in 2026–2027 as large projects complete their ramp—requiring little to no additional CapEx. The company's scaled, low-cost resources at Wodgina, Greenbushes, and Salar de Atacama provide capital-efficient brownfield opportunities to fuel future growth, meaning that near-term volume stability does not impair long-term secular growth trajectories in energy storage and EVs.
Albemarle's balance sheet strength and proactive debt reduction are creating underappreciated financial flexibility that enables strategic optionality amid market volatility. Following the Q1 repayment of $1.3 billion in debt using proceeds from the Eurecat joint venture and Ketjen divestiture, the company reduced its weighted average interest rate to 3.1%, lowered annual interest expense by approximately $60 million, and ended the quarter with a net debt-to-EBITDA leverage ratio of 1x—with no major debt maturities until late 2028. This financial resilience allows Albemarle to navigate supply chain disruptions and geopolitical uncertainties without compromising its investment-grade profile, while maintaining the capacity to pursue value-accretive brownfield projects at existing assets like Greenbushes, Wodgina, and Salar de Atacama. The company's conservative balance sheet posture, combined with its ability to generate $346 million in operating cash flow and $248 million in free cash flow in Q1, positions it to capitalize on opportunistic investments during market downturns—such as advancing the Kings Mountain project or expanding DLE capabilities at Salar de Atacama—when others may be constrained by leverage concerns.

▼ Bear case

Albemarle's Energy Storage segment faces significant near-term margin pressure that the market may be overlooking, driven by the timing of spodumene inventory consumption and structural inefficiencies in long-term contract pricing. Although Q1 adjusted EBITDA nearly tripled year-over-year to $664 million, this was partly fueled by consuming lower-cost spodumene purchased in Q4 2025, creating a temporary uplift that will normalize as higher-priced inventory flows through the supply chain. Management acknowledged that Energy Storage EBITDA margins are expected to decrease sequentially in Q2 due to this inventory timing effect, even assuming flat lithium market pricing, with full-year guidance assuming a mid-50% margin range only under flat pricing scenarios—a condition that may not hold if spot prices retreat from current levels. Furthermore, the gap between Albemarle's average realized price ($17/kg in Q1) and spot market prices persists due to the one-quarter lag in long-term contracts and the dilutive effect of spodumene sales on a lithium carbonate equivalent (LCE) basis, which could limit upside capture if spot prices remain elevated or increase further.
Albemarle's Specialties segment remains vulnerable to persistent supply chain disruptions and geopolitical tensions that management has not fully mitigated, despite optimistic guidance revisions. While the company cites cost and productivity improvements as offsetting an estimated $70 million to $90 million in unmitigated supply chain costs, these improvements are already being deployed to counter known headwinds, leaving little buffer for additional shocks. Operations at the Jordan Bromine Company joint venture, though recovered from flooding, continue to operate amid ongoing despite "geopolitical tensions and disruptions in the region," and management conceded that outlooks for end markets like petrochemicals and oil and gas remain volatile due to these tensions. The Specialties outlook increase to $225 million–$275 million in adjusted EBITDA relies on "stronger-than-expected pricing and volumes" that may not be sustainable if bromine demand weakens in key industrial end markets or if regional instability disrupts logistics or raw material access. Furthermore, the company acknowledged that only 20% or less of Specialties sales are exposed to the China bromine index, yet it continues to highlight this index as a market indicator—suggesting potential misalignment between reported performance drivers and the narrative used to justify guidance increases.
Albemarle's long-term growth projects, including Kings Mountain and commercial DLE at Salar de Atacama, face substantial execution and permitting risks that are underappreciated in current valuations, despite management's expressed confidence. While the company notes progress—such as federal mining permits at Kings Mountain and pilot plant success at La Negra achieving over 94% lithium recovery—it simultaneously acknowledges that these initiatives remain in "predevelopment evaluations" with no final investment decision made, and that commercial DLE investments would be "phased in a prudent manner, contingent on approvals and investment decisions." This cautious language contrasts with the optimistic framing of these assets as "world-class" and "strategic," potentially overstating near-term value creation. Additionally, the company's reliance on brownfield ramp-ups at Greenbushes and Wodgina for near-term volume growth carries operational risk, as evidenced by ongoing discussions about grade recoveries, production stability, and safety concerns at Greenbushes—issues raised by joint venture partners and acknowledged by management as requiring long-term improvement programs. The expectation that completing the current growth phase requires "little to no additional CapEx" may prove optimistic if unforeseen technical or regulatory challenges arise during asset ramp-ups or if higher-quality ore availability at Wodgina does not improve as anticipated in the December quarter.

Albemarle's Energy Storage segment faces significant near-term margin pressure that the market may be overlooking, driven by the timing of spodumene inventory consumption and structural inefficiencies in long-term contract pricing. Although Q1 adjusted EBITDA nearly tripled year-over-year to $664 million, this was partly fueled by consuming lower-cost spodumene purchased in Q4 2025, creating a temporary uplift that will normalize as higher-priced inventory flows through the supply chain. Management acknowledged that Energy Storage EBITDA margins are expected to decrease sequentially in Q2 due to this inventory timing effect, even assuming flat lithium market pricing, with full-year guidance assuming a mid-50% margin range only under flat pricing scenarios—a condition that may not hold if spot prices retreat from current levels. Furthermore, the gap between Albemarle's average realized price ($17/kg in Q1) and spot market prices persists due to the one-quarter lag in long-term contracts and the dilutive effect of spodumene sales on a lithium carbonate equivalent (LCE) basis, which could limit upside capture if spot prices remain elevated or increase further.
Albemarle's Specialties segment remains vulnerable to persistent supply chain disruptions and geopolitical tensions that management has not fully mitigated, despite optimistic guidance revisions. While the company cites cost and productivity improvements as offsetting an estimated $70 million to $90 million in unmitigated supply chain costs, these improvements are already being deployed to counter known headwinds, leaving little buffer for additional shocks. Operations at the Jordan Bromine Company joint venture, though recovered from flooding, continue to operate amid ongoing despite "geopolitical tensions and disruptions in the region," and management conceded that outlooks for end markets like petrochemicals and oil and gas remain volatile due to these tensions. The Specialties outlook increase to $225 million–$275 million in adjusted EBITDA relies on "stronger-than-expected pricing and volumes" that may not be sustainable if bromine demand weakens in key industrial end markets or if regional instability disrupts logistics or raw material access. Furthermore, the company acknowledged that only 20% or less of Specialties sales are exposed to the China bromine index, yet it continues to highlight this index as a market indicator—suggesting potential misalignment between reported performance drivers and the narrative used to justify guidance increases.
Albemarle's long-term growth projects, including Kings Mountain and commercial DLE at Salar de Atacama, face substantial execution and permitting risks that are underappreciated in current valuations, despite management's expressed confidence. While the company notes progress—such as federal mining permits at Kings Mountain and pilot plant success at La Negra achieving over 94% lithium recovery—it simultaneously acknowledges that these initiatives remain in "predevelopment evaluations" with no final investment decision made, and that commercial DLE investments would be "phased in a prudent manner, contingent on approvals and investment decisions." This cautious language contrasts with the optimistic framing of these assets as "world-class" and "strategic," potentially overstating near-term value creation. Additionally, the company's reliance on brownfield ramp-ups at Greenbushes and Wodgina for near-term volume growth carries operational risk, as evidenced by ongoing discussions about grade recoveries, production stability, and safety concerns at Greenbushes—issues raised by joint venture partners and acknowledged by management as requiring long-term improvement programs. The expectation that completing the current growth phase requires "little to no additional CapEx" may prove optimistic if unforeseen technical or regulatory challenges arise during asset ramp-ups or if higher-quality ore availability at Wodgina does not improve as anticipated in the December quarter.

Geographical Breakdown of Revenue (2025)

Peer Comparison

Companies in the Specialty Chemicals

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	LIN	Linde Plc	237.95 Bn	33.52	6.87	24.68 Bn
2	SHW	Sherwin Williams Co	78.17 Bn	30.07	3.27	11.70 Bn
3	ECL	Ecolab Inc.	76.02 Bn	30.01	4.73	8.24 Bn
4	APD	Air Products & Chemicals, Inc.	66.38 Bn	47.14	5.33	17.40 Bn
5	PPG	Ppg Industries Inc	26.02 Bn	3,717.41	1.61	7.83 Bn
6	LYB	LyondellBasell Industries N.V.	22.51 Bn	-28.53	0.76	11.45 Bn
7	SQM	Chemical & Mining Co Of Chile Inc	19.70 Bn	21.77	3.72	4.79 Bn
8	IFF	International Flavors & Fragrances Inc	19.51 Bn	-102.16	1.81	5.82 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password